Drugs / halofuginone
halofuginone
also known as
HT-100 · Halocur · Halofuginon · Halofuginona · Halofuginone hbr · HALOFUGINONE HYDROBROMIDE · Kriptazen · NSC-713205 · +3 more
Trials 5
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT00027677 | Aug 2001 → Feb 2004 | cancer of unknown primary site | European Organisation for Research and Treatment of Cancer - EORTC | Completed | No outcome recorded |
| Phase 1/21 trial | ||||||
| Phase 1/2 | NCT01847573 | May 2013 → Mar 2016 | Duchenne muscular dystrophy | Processa Pharmaceuticals | Terminated | No outcome recorded |
| Phase 23 trials | ||||||
| Phase 2 | NCT02525302 | May 2015 → Dec 2016 | Duchenne muscular dystrophy | Akashi Therapeutics | Terminated | No outcome recorded |
| Phase 2 | NCT01978366 | Oct 2013 → Apr 2016 | Duchenne muscular dystrophy | Processa Pharmaceuticals | Terminated | No outcome recorded |
| Phase 2 | NCT00064142 | May 2003 → Dec 2006 | Kaposi's sarcoma | National Cancer Institute (NCI) | Completed | No outcome recorded |
Evidence & citations 14 cited values
Every value below carries the sentence it was read from. 6 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | halofuginone | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00027677 ↗ |
| Known as | Halocur | ChEMBL registry synonym — accepted as the source's own label CHEMBL1197091 ↗ |
| Known as | Halofuginon | ChEMBL registry synonym — accepted as the source's own label CHEMBL1197091 ↗ |
| Known as | Halofuginona | ChEMBL registry synonym — accepted as the source's own label CHEMBL1197091 ↗ |
| Known as | Halofuginone hbr | ChEMBL registry synonym — accepted as the source's own label CHEMBL1197091 ↗ |
| Known as | HALOFUGINONE HYDROBROMIDE | ChEMBL registry synonym — accepted as the source's own label CHEMBL1197091 ↗ |
| Known as | HT-100 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02525302 ↗ |
| Known as | Kriptazen | ChEMBL registry synonym — accepted as the source's own label CHEMBL1197091 ↗ |
| Known as | NSC-713205 | ChEMBL registry synonym — accepted as the source's own label CHEMBL1197091 ↗ |
| Known as | Rac-halofuginone | ChEMBL registry synonym — accepted as the source's own label CHEMBL1197091 ↗ |
| Known as | RU-19110 | ChEMBL registry synonym — accepted as the source's own label CHEMBL1197091 ↗ |
| Known as | Stenorol | ChEMBL registry synonym — accepted as the source's own label CHEMBL1197091 ↗ |
| Modality | Small molecule | “a small molecule therapeutic with anti-fibrotic properties” NCT02525302 ↗ |
| Route | Oral | “Patients receive oral halofuginone hydrobromide once daily on days 1 and 4-14 of course 1 and on days 1-14 of subsequent courses.” NCT00027677 ↗ |